日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

FDA Approval Summary: Niraparib plus Abiraterone Acetate Fixed-Dose Combination for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

FDA批准摘要：尼拉帕尼联合醋酸阿比特龙固定剂量组合用于治疗BRCA突变转移性去势抵抗性前列腺癌

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-0883
Maguire, William F; Chi, Dow-Chung; Agrawal, Sundeep; Joeng, Hee-Koung; Kim-McOlash, Sarah; Manheng, Wimolnut; Bulatao, Ilynn; Sanchez-Solana, Beatriz; Pathak, Anand; Lee, Alice; Han, Yu; Ricks, Tiffany K; Hamed, Salaheldin S; Fiero, Mallorie H; Pierce, William F; Kalavar, Shyam; Ghosh, Soma; Leighton, John K; Tang, Shenghui; Amiri-Kordestani, Laleh; Kluetz, Paul G; Suzman, Daniel L
肿瘤
前列腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Anti-muscarinic 3 antibodies associate with a severe clinical phenotype in patients with systemic sclerosis

抗毒蕈碱受体3抗体与系统性硬化症患者的严重临床表型相关

期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/keaf197
Ayla, Ali Y; Kalavar, Naveen R; Pimentel, Mark; Morales, Walter; Hummers, Laura K; Shah, Ami A; Hughes, Michael; McMahan, Zsuzsanna H
信号转导
系统性硬化症
免疫/内分泌
发表日期：2025
文献求助 收藏

Trends in utilization of imaging among ophthalmic-related emergency department visits in the United States

美国眼科急诊就诊患者影像检查使用趋势

期刊:Frontiers in Ophthalmology
影响因子:0.9
doi:10.3389/fopht.2025.1706213
Chou, Brandon; Shah, Serena M; Kalavar, Meghana; Sridhar, Jayanth; MacIntosh, Peter; Lee, Andrew G
发表日期：2025
文献求助 收藏

US Food and Drug Administration Approval Summary: Capivasertib With Fulvestrant for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer With PIK3CA/AKT1/PTEN Alterations

美国食品药品监督管理局批准摘要：Capivasertib联合Fulvestrant用于治疗激素受体阳性、人表皮生长因子受体2阴性且伴有PIK3CA/AKT1/PTEN改变的局部晚期或转移性乳腺癌

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.24.00427
Dilawari, Asma; Buturla, James; Osgood, Christy; Gao, Xin; Chen, Wei; Ricks, Tiffany K; Schaefer, Timothy; Avasarala, Sreedevi; Reyes Turcu, Francisca; Pathak, Anand; Kalavar, Shyam; Bhatnagar, Vishal; Collazo, Justin; Rahman, Nam Atiqur; Mixter, Bronwyn; Tang, Shenghui; Pazdur, Richard; Kluetz, Paul; Amiri-Kordestani, Laleh
肿瘤
肿瘤免疫
AKT1
信号转导
乳腺癌
PTEN
Human
AKT
免疫/内分泌
发表日期：2024
文献求助 收藏

US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer

美国食品药品监督管理局批准摘要：他拉唑帕尼联合恩扎卢胺治疗同源重组修复基因突变转移性去势抵抗性前列腺癌患者

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.23.02182
Heiss, Brian L; Chang, Elaine; Gao, Xin; Truong, Tien; Brave, Michael H; Bloomquist, Erik; Shah, Ankit; Hamed, Salaheldin; Kraft, Jeffrey; Chiu, Haw-Jyh; Ricks, Tiffany K; Tilley, Amy; Pierce, William F; Tang, Liuya; Abukhdeir, Abdelrahmman; Kalavar, Shyam; Philip, Reena; Tang, Shenghui; Pazdur, Richard; Amiri-Kordestani, Laleh; Kluetz, Paul G; Suzman, Daniel L
肿瘤
前列腺癌
肿瘤免疫
发表日期：2024
文献求助 收藏

US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, ESR1-Mutated Advanced or Metastatic Breast Cancer

美国食品药品监督管理局批准摘要：Elacestrant 用于治疗雌激素受体阳性、人表皮生长因子受体 2 阴性、ESR1 突变的晚期或转移性乳腺癌

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.23.02112
Shah, Mirat; Lingam, Hima; Gao, Xin; Gittleman, Haley; Fiero, Mallorie H; Krol, Danielle; Biel, Nikolett; Ricks, Tiffany K; Fu, Wentao; Hamed, Salaheldin; Li, Fang; Sun, Jillian Jielin; Fan, Jianghong; Schuck, Robert; Grimstein, Manuela; Tang, Liuya; Kalavar, Shyam; Abukhdeir, Abdelrahmman; Pathak, Anand; Ghosh, Soma; Bulatao, Ilynn; Tilley, Amy; Pierce, William F; Mixter, Bronwyn D; Tang, Shenghui; Pazdur, Richard; Kluetz, Paul; Amiri-Kordestani, Laleh
肿瘤
肿瘤免疫
信号转导
乳腺癌
Human
免疫/内分泌
发表日期：2024
文献求助 收藏

Sepsis Unveils T-cell Large Granular Lymphocytic Leukemia in the Setting of End-Stage Renal Disease: A Rare Hematologic Malignancy

脓毒症揭示终末期肾病背景下的T细胞大颗粒淋巴细胞白血病：一种罕见的血液系统恶性肿瘤

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.55325
Chowdhury, Tutul; Kunwar, Kalendra; Mustafa, Fareeza; Sajeev, Annmarie T; Sharma, Mrinal; Pasha, Muhammad N; Kalavar, Madhumati
肿瘤
T细胞
肿瘤免疫
炎症/感染
败血症
白血病
T细胞
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

Cyclophosphamide, Bortezomib, and Dexamethasone and Severe Systolic Heart Failure: A Case Report

环磷酰胺、硼替佐米和地塞米松治疗严重收缩性心力衰竭：病例报告

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.56966
Pandey, Sagar; Tan, Ernestine Faye S; Bellamkonda, Amulya; Aryal, Binit; Kalavar, Madhumati
心力衰竭
心血管
发表日期：2024
文献求助 收藏

FDA Approval Summary: Atezolizumab as Adjuvant Treatment following Surgical Resection and Platinum-Based Chemotherapy for Stage II to IIIA NSCLC

FDA批准摘要：阿特珠单抗作为II期至IIIA期非小细胞肺癌手术切除和铂类化疗后的辅助治疗

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-3699
Mathieu, Luckson N; Larkins, Erin; Sinha, Arup K; Mishra-Kalyani, Pallavi S; Jafri, Samina; Kalavar, Shyam; Ghosh, Soma; Goldberg, Kirsten B; Pazdur, Richard; Beaver, Julia A; Singh, Harpreet
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRα-Positive, Platinum-Resistant Ovarian Cancer

FDA批准摘要：Mirvetuximab Soravtansine-Gynx用于治疗FRα阳性、铂类耐药卵巢癌

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-23-0991
Dilawari, Asma; Shah, Mirat; Ison, Gwynn; Gittleman, Haley; Fiero, Mallorie H; Shah, Ankit; Hamed, Salaheldin S; Qiu, Junshan; Yu, Jingyu; Manheng, Wimolnut; Ricks, Tiffany K; Pragani, Rajan; Arudchandran, Arulvathani; Patel, Paresma; Zaman, Shadia; Roy, Arpita; Kalavar, Shyam; Ghosh, Soma; Pierce, William F; Rahman, Nam Atiqur; Tang, Shenghui; Mixter, Bronwyn D; Kluetz, Paul G; Pazdur, Richard; Amiri-Kordestani, Laleh
肿瘤
肿瘤免疫
卵巢癌
发表日期：2023
文献求助 收藏